REPLIGEN CORP (RGEN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for RGEN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RGEN | President and Chief Executive Officer, Director; President and CEO | 56 | ["Public Company Board/CEO", "Risk Oversight", "Finance & Capital Markets", "Manufacturing & Global Operations", "Strategic Planning and M&A", "Life Sciences Technology & Innovation", "Commercial Sales & Marketing", "CEO of Ascensus Specialties", "12 years with Cytiva", "12 years with Lonza", "Master's degree in Chemistry", "MBA from CESMA Business School"] | [] | 2026 |
Biography sourced from the proxy statement filing.
President, Chief Executive Officer and Director. Mr. Loeillot will continue to serve as the Company's principal executive officer in his role as Chief Executive Officer.